Personalized cell therapy has become a growing option for treatment of cancer and many other ailments. See MoreUsing engineered T cells that express chimeric antigen receptors or modified T cell receptors are becoming pivotal new approaches for targeting cancer cells.
The process of manufacturing genetically-modified T cells for cancer therapies or other applications may initially require the isolation of T cells or T cell subsets from
Leukopaks
or
whole blood samples
. STEMCELL Technologies provides fast, easy and column-free immunomagnetic
or immunodensity
cell separation platforms for the isolation of highly purified T cells in as little as 8 minutes. The purified cells are immediately ready for T cell activation and expansion, the next steps in the T cell engineering workflow.
From sourcing your starting sample to downstream T cell analysis, explore our complete portfolio of products to support your human T cell research workflow.